Awaiting development: Guidance and quality standards
Showing 1 to 1 of 1
| Title | Type |
|---|---|
| Denosumab biosimilar for Giant cell-rich tumours of bone or Skeletal events in bone malignancies ID12150 | Technology appraisal guidance |
| Title | Type |
|---|---|
| Denosumab biosimilar for Giant cell-rich tumours of bone or Skeletal events in bone malignancies ID12150 | Technology appraisal guidance |